📆 Monday, November 13
► European shares rose at the start of the week, with the Stoxx 600 Index trading around 0.6% higher. However, the gains were already made in after-hours trading on Friday and were influenced by the positive movements on Wall Street. European shares even gave back a large part of Friday's after-hours gains – as predicted by our chief analyst Robert Lindner. Healthcare stocks in particular, especially Novo Nordisk, posted a strong performance after the company presented positive results from a study on its weight-loss drug Wegovy.
► Despite these gains in Europe, futures for the S&P 500 and the Nasdaq 100 in the US indicated a slight decrease, tempering the optimism following the tech-led rally on Friday. This decline coincided with Moody’s adjustment of the US credit rating outlook from stable to negative. This change reflects concerns over increasing fiscal deficits and political conflicts. US markets are closely monitoring the upcoming consumer price data, anticipated to show a decrease in inflation to 3.3% year-on-year for October. This data is crucial for understanding the potential direction of the Federal Reserve’s policy on interest rates.
Subscribe to see more